Archana Asundi1, Maggie Stanislawski2, Payal Mehta3, Anna E Baron4, Hillary J Mull5, P Michael Ho2, Peter J Zimetbaum6, Kalpana Gupta3, Westyn Branch-Elliman3. 1. Division of Infectious Diseases,Boston Medical Center,Boston, Massachusetts. 2. Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care,Seattle, Washington, and Denver, Colorado. 3. Department of Medicine,Division of Infectious Diseases, Boston VA Healthcare System,West Roxbury, Massachusetts. 4. Department of Epidemiology,University of Colorado School of Public Health,Aurora, Colorado. 5. Center for Healthcare Organization and Implementation Research (CHOIR),Boston Veterans Affairs Healthcare System, Boston, Massachusetts. 6. Division of Cardiology,Beth Israel Deaconess Medical Center,Boston, Massachusetts.
Abstract
OBJECTIVE: To measure the association between receipt of specific infection prevention interventions and procedure-related cardiac implantable electronic device (CIED) infections. DESIGN: Retrospective cohort with manually reviewed infection status. SETTING: Setting: National, multicenter Veterans Health Administration (VA) cohort. PARTICIPANTS: Sampling of procedures entered into the VA Clinical Assessment Reporting and Tracking-Electrophysiology (CART-EP) database from fiscal years 2008 through 2015. METHODS: A sample of procedures entered into the CART-EP database underwent manual review for occurrence of CIED infection and other clinical/procedural variables. The primary outcome was 6-month incidence of CIED infection. Measures of association were calculated using multivariable generalized estimating equations logistic regression. RESULTS: We identified 101 procedure-related CIED infections among 2,098 procedures (4.8% of reviewed sample). Factors associated with increased odds of infections included (1) wound complications (adjusted odds ratio [aOR], 8.74; 95% confidence interval [CI], 3.16-24.20), (2) revisions including generator changes (aOR, 2.4; 95% CI, 1.59-3.63), (3) an elevated international normalized ratio (INR) >1.5 (aOR, 1.56; 95% CI, 1.12-2.18), and (4) methicillin-resistant Staphylococcus colonization (aOR, 9.56; 95% CI, 1.55-27.77). Clinically effective prevention interventions included preprocedural skin cleaning with chlorhexidine versus other topical agents (aOR, 0.41; 95% CI, 0.22-0.76) and receipt of β-lactam antimicrobial prophylaxis versus vancomycin (aOR, 0.60; 95% CI, 0.37-0.96). The use of mesh pockets and continuation of antimicrobial prophylaxis after skin closure were not associated with reduced infection risk. CONCLUSIONS: These findings regarding the real-world clinical effectiveness of different prevention strategies can be applied to the development of evidence-based protocols and infection prevention guidelines specific to the electrophysiology laboratory.
OBJECTIVE: To measure the association between receipt of specific infection prevention interventions and procedure-related cardiac implantable electronic device (CIED) infections. DESIGN: Retrospective cohort with manually reviewed infection status. SETTING: Setting: National, multicenter Veterans Health Administration (VA) cohort. PARTICIPANTS: Sampling of procedures entered into the VA Clinical Assessment Reporting and Tracking-Electrophysiology (CART-EP) database from fiscal years 2008 through 2015. METHODS: A sample of procedures entered into the CART-EP database underwent manual review for occurrence of CIED infection and other clinical/procedural variables. The primary outcome was 6-month incidence of CIED infection. Measures of association were calculated using multivariable generalized estimating equations logistic regression. RESULTS: We identified 101 procedure-related CIED infections among 2,098 procedures (4.8% of reviewed sample). Factors associated with increased odds of infections included (1) wound complications (adjusted odds ratio [aOR], 8.74; 95% confidence interval [CI], 3.16-24.20), (2) revisions including generator changes (aOR, 2.4; 95% CI, 1.59-3.63), (3) an elevated international normalized ratio (INR) >1.5 (aOR, 1.56; 95% CI, 1.12-2.18), and (4) methicillin-resistant Staphylococcus colonization (aOR, 9.56; 95% CI, 1.55-27.77). Clinically effective prevention interventions included preprocedural skin cleaning with chlorhexidine versus other topical agents (aOR, 0.41; 95% CI, 0.22-0.76) and receipt of β-lactam antimicrobial prophylaxis versus vancomycin (aOR, 0.60; 95% CI, 0.37-0.96). The use of mesh pockets and continuation of antimicrobial prophylaxis after skin closure were not associated with reduced infection risk. CONCLUSIONS: These findings regarding the real-world clinical effectiveness of different prevention strategies can be applied to the development of evidence-based protocols and infection prevention guidelines specific to the electrophysiology laboratory.
Authors: Khaldoun G Tarakji; Suneet Mittal; Charles Kennergren; Ralph Corey; Jeanne E Poole; Edward Schloss; Jose Gallastegui; Robert A Pickett; Rudolph Evonich; François Philippon; Janet M McComb; Steven F Roark; Denise Sorrentino; Darius Sholevar; Edmond Cronin; Brett Berman; David Riggio; Mauro Biffi; Hafiza Khan; Marc T Silver; Jack Collier; Zayd Eldadah; David J Wright; Jeff D Lande; Daniel R Lexcen; Alan Cheng; Bruce L Wilkoff Journal: N Engl J Med Date: 2019-03-17 Impact factor: 91.245
Authors: Preeti Mehrotra; Kalpana Gupta; Judith Strymish; Daniel B Kramer; Anne Lambert-Kerzner; P Michael Ho; Westyn Branch-Elliman Journal: Infect Control Hosp Epidemiol Date: 2017-01-20 Impact factor: 3.254
Authors: Jonathan A T Sandoe; Gavin Barlow; John B Chambers; Michael Gammage; Achyut Guleri; Philip Howard; Ewan Olson; John D Perry; Bernard D Prendergast; Michael J Spry; Richard P Steeds; Muzahir H Tayebjee; Richard Watkin Journal: J Antimicrob Chemother Date: 2014-10-29 Impact factor: 5.790
Authors: Konstantinos Z Vardakas; Kyriakos K Trigkidis; Eleni Boukouvala; Matthew E Falagas Journal: Int J Antimicrob Agents Date: 2016-04-27 Impact factor: 5.283
Authors: Joy Uwemedimo; Deirdre Fitzgerald-Hughes; Peter Kinnevey; Anna Shore; David Coleman; Hilary Humphreys; Toney Thomas Poovelikunnel Journal: J Infect Prev Date: 2020-06-13
Authors: Yves Longtin; Philippe Gervais; David H Birnie; Jia Wang; Marco Alings; François Philippon; Ratika Parkash; Jaimie Manlucu; Paul Angaran; Claus Rinne; Benoit Coutu; R Aaron Low; Vidal Essebag; Carlos Morillo; Damian Redfearn; Satish Toal; Giuliano Becker; Michel Degrâce; Bernard Thibault; Eugene Crystal; Stanley Tung; John LeMaitre; Omar Sultan; Matthew Bennett; Jamil Bashir; Felix Ayala-Paredes; Leon Rioux; Martin E W Hemels; Leon H R Bouwels; Derek V Exner; Paul Dorian; Stuart J Connolly; Andrew D Krahn Journal: Open Forum Infect Dis Date: 2021-10-14 Impact factor: 3.835
Authors: Hillary J Mull; Kelly L Stolzmann; Marlena H Shin; Emily Kalver; Marin L Schweizer; Westyn Branch-Elliman Journal: JAMA Netw Open Date: 2020-09-01